1 min read
Add as a preferred source on Google

Xtant Medical Holdings Announces Board-Led Review as Q3 Revenue Falls

Revenue was $24.3 million, down 26.9% year over year and $1.18 million below estimates. GAAP earnings per share was a loss of $0.03, missing estimates by one cent.

A titanium spinal implant rests beside a porous bone graft model / TokenPost.ai
A titanium spinal implant rests beside a porous bone graft model / TokenPost.ai

Xtant Medical Holdings Inc. announced a board-led strategic review as its third-quarter revenue fell 26.9% year over year and GAAP earnings per share missed estimates.

Revenue totaled $24.3 million.

The revenue figure was $1.18 million below estimates.

GAAP earnings per share was a loss of $0.03.

That per-share result missed estimates by one cent.

The company posted a $1.5 million quarterly loss on an adjusted EBITDA basis, a non-GAAP measure.

Xtant’s board is leading the strategic review process.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…